In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Ruben A. Mesa examines the use of JAK inhibitors as a treatment option for patients with cytopenic myelofibrosis (CF).
Treatment option for Cytopenic Myelofibrosis (MF)
